Skip to main content
Caplight Logo









Avicena Systems

Avicena Systems

Private
PerthHealthcare & Life Scienceshttps://avicenasystems.com/

Last Round

Grant

Feb 13, 2024

Total Funding Raised

$11.06M

Company Overview

Avicena Systems is a biotechnology company that develops and manufactures ultra-high throughput molecular diagnostic and biosecurity screening systems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology, Environmental Monitoring

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

molecular diagnosticspathogen detectionloop-mediated isothermal amplificationLAMPbiosecurityrapid testingpoint-of-care diagnosticsPOC testingmedical devicehigh-throughput screeningbiotech equipmentreagentsconsumablesclinical diagnosticslab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avicena Systems Comparables

Compare Avicena Systems with similar companies based on industry and business-model similarity.

No public comparables are available for Avicena Systems. Request access to learn about comparables coverage.

Request access

Avicena Systems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 13, 2024
SeedOct 3, 2022
GrantSep 24, 2021
GrantJun 16, 2021
GrantJan 30, 2021
Grant
Oct 1, 2020

Key People

Founding team and executive leadership

Mark Sheridan

Chief Operating Officer

Executive Team

Avicena Systems Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2024

    Secured $2M from Australian Government and other entities.

  • Oct 3, 2022

    Raised $5.76M in a seed funding round.

Avicena Systems Filings

Explore SEC and related filing metadata, where available.

Avicena Systems filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avicena Systems's valuation, stock price, and market status.

Is Avicena Systems a public or private company?

Avicena Systems is a private company.

What is the current stock price of Avicena Systems?

Avicena Systems is a private company with no public stock price. Caplight tracks Avicena Systems's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Avicena Systems worth (valuation)?

Valuation information for Avicena Systems is not publicly available.

Can I buy Avicena Systems stock?

Avicena Systems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avicena Systems's last funding round?

Avicena Systems's most recent funding round was Grant on February 13, 2024.

Who are the main investors in Avicena Systems?

Key investors in Avicena Systems include Government of Western Australia, Australian Government Department of Industry, Science and Resources, Australian Government, Department of Defence.

Will Avicena Systems IPO soon?

No public IPO plans have been announced for Avicena Systems.

How can I track Avicena Systems secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avicena Systems's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPerth
Employee Range12
Year Founded2020
Last FundingFeb 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?